Wang Li
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- RNA modifications and cancer
- Circular RNAs in diseases
- Cancer-related gene regulation
- Epigenetics and DNA Methylation
- Gut microbiota and health
Papers in
-
- Circular RNAs in diseases 4
- Gut microbiota and health 2
-
- Ferroptosis and cancer prognosis 3
- Renal cell carcinoma treatment 2
- Co-authors
- Junnian Zheng (3 shared papers)Jiacun Chen (2 shared papers)Lijun Mao (1 shared paper)Junqi Wang (1 shared paper)Chunhua Yang (1 shared paper)Guang Yang (1 shared paper)Zhaojie Li (1 shared paper)Cheng Peng (1 shared paper)
- Journals
- Cancer Letters (1 paper)PLoS ONE (1 paper)Immunopharmacology and Immunotoxicology (1 paper)Oral Oncology (1 paper)International Journal of Molecular Medicine (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Wang Li
34 papers receiving 356 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 86
- Molecular Biology 167
- Biochemistry 13
- Pulmonary and Respiratory Medicine 52
- Gastroenterology 8
Countries citing papers authored by Wang Li
This map shows the geographic impact of Wang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wang Li more than expected).
Fields of papers citing papers by Wang Li
This network shows the impact of papers produced by Wang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wang Li. The network helps show where Wang Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Wang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 56 | |
| 2 | 2013 | 47 | |
| 3 | 2018 | 46 | |
| 4 | 2020 | 25 | |
| 5 | 2023 | 23 | |
| 6 | 2022 | 22 | |
| 7 | p53 gene mutations in multifocal esophageal precancerous and cancerous lesions in patients with esophageal cancer in high risk northern China | 1999 | 14 |
| 8 | 2022 | 13 | |
| 9 | 2022 | 13 | |
| 10 | 2019 | 12 | |
| 11 | 2020 | 11 | |
| 12 | 2023 | 11 | |
| 13 | 2022 | 8 | |
| 14 | Identification of PDCD1 and PDCD1LG2 as Prognostic Biomarkers and Associated with Immune Infiltration in Hepatocellular Carcinoma | 2022 | 7 |
| 15 | Antitumor activity of polysaccharide from Aralia elata Seem and the effect on immune functions in tumor-bearing mice | 2011 | 5 |
| 16 | 2023 | 4 | |
| 17 | 2023 | 4 | |
| 18 | 2021 | 4 | |
| 19 | 2011 | 4 | |
| 20 | 2024 | 3 |
About Wang Li
Wang Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Pharmacology, having authored 37 papers that have together received 358 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (7 papers), Circular RNAs in diseases (4 papers), Cancer-related molecular mechanisms research (4 papers), Ferroptosis and cancer prognosis (3 papers), Renal cell carcinoma treatment (2 papers), Gut microbiota and health (2 papers), Mycorrhizal Fungi and Plant Interactions (2 papers) and Plant Pathogens and Fungal Diseases (2 papers). The work is most often cited by research in Cancer Research (86 citations), Molecular Biology (167 citations), Biochemistry (13 citations), Pulmonary and Respiratory Medicine (52 citations) and Gastroenterology (8 citations). Wang Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Junnian Zheng, Jiacun Chen, Lijun Mao, Junqi Wang, Chunhua Yang, Guang Yang, Zhaojie Li, Cheng Peng, Linlin Li and Peng-jin Mei. Their work appears in journals such as Cancer Letters, PLoS ONE, Immunopharmacology and Immunotoxicology, Oral Oncology and International Journal of Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.